[Non anti-HLA antibodies and acute rejection: A critical viewpoint]

Abstract

In solid organ transplantation, the deleterious effect of antibodies directed against donor HLA antigens, whether preformed or de novo, is well established. Anti-HLA antibodies have been associated not only with the risk of antibody-mediated rejection but also with late graft dysfunction and are now considered to be the leading cause of allograft loss after renal transplantation. In addition to HLA antibodies, the possible involvement of non-HLA antibodies targeting donor endothelial cells has long been the subject of intense research. The purpose of this review is to discuss current knowledge and remaining issues related to the involvement of non-HLA antibodies in solid organ transplantation. More specifically, the clinical data underlying the hypothesis of the role of non-HLA antibodies will be discussed, as well as the different techniques for antibody detection, their clinical relevance and their antigenic targets.

Keywords: Agression endothéliale; Anti-endothelial cell antibody; Anticorps anticellules endothéliales; Anticorps non-HLA; Endothelial injury; Non-HLA antibody; Rejection; Rejet; Transplantation.